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In the United States, 25% of infant formula
is based on soy protein (American Academy
of Pediatrics Committee on Nutrition 1998).
Although soy infant formula has been in use
for 60 years in the United States, formula-
related illness reports have been largely
absent, except for case reports of goiter in the
late 1950s (van Wyk et al. 1959), a problem
resolved by reformulation (Shepard et al.
1960). More recently, an outbreak of thi-
amine deficiency in Israeli infants in 2003
was attributed to defective soy formula, man-
ufactured exclusively for the Israeli market
(Fattal-Valevski et al. 2005). Soy formula
contains estrogenic isoﬂavones (Setchell et al.
1998). The presence of these compounds is
the basis of most health claims made for soy
foods, especially for postmenopausal women.
Adults rarely exceed 25% of calories from soy
(Baird et al. 1995); infants fed soy formula
get 100%. Although the soy isoflavones are
weak estrogens, soy formula contains so
much of them that estimates of daily estro-
genic dose per kilogram are equivalent to
0.01 to > 1 hormonal contraceptive pill per
day, depending on the potency estimate used
(Chen and Rogan 2004; Klein 1998).
Soy formulas do not appear to estrogenize
human infants, but such an effect might be
overlooked because the term newborn is
already responding to the mother’s circulating
estrogen. The responses of the fetal breast and
genitalia form part of the Ballard score for
estimating gestational age (Ballard et al. 1979,
1991). If soy formula were to prolong physio-
logic estrogenization, it would not be noticed
unless it was striking or specifically sought.
The U.S. National Toxicology Program
Center for the Evaluation of Risks to Human
Reproduction Expert Panel recently reviewed
the existing human data on the developmen-
tal toxicity of soy formula. The panel found
the data insufﬁcient to conclude whether soy
formula would produce reproductive toxicity.
They also noted that the existing human data
were “limited by small samples sizes, conﬂict-
ing results, and historical studies that used soy
infant formula of different composition than
the formula being sold currently” (Rozman
et al. 2006). 
In designing a study to test the hypothesis
that soy formula prolonged physiologic estrog-
enization, we found the natural history of
estrogen effects ex utero not sufficiently well
described. We thus undertook a pilot study of
breast and genital anatomy, milk secretion,
and vaginal cytology over the ﬁrst 6 months of
life, which we report here. The purpose of this
study was explicitly to examine methods and
to assess which of the characteristics examined
might exhibit declines from younger to older
children, a pattern consistent with response to
the withdrawal of maternal estrogen. 
Patients and Methods
Recruitment and study design. This physical
examination pilot study was conducted at the
Children’s Hospital of Philadelphia (CHOP)
and afﬁliated clinics during 2004–2005. The
institutional review boards at CHOP, the
University of Pennsylvania, and the National
Institute of Environmental Health Sciences
approved the study. 
We recruited volunteer children from the
Hospital of the University of Pennsylvania
nursery, and CHOP clinics and satellite clin-
ics. Families had to have been consistent in
the child’s feeding regimen (Table 1).
Eligibility criteria included gestational age
37–41 weeks, birth weight 2,500–4,500 g,
palpable testes if male, and no major illness
or birth defect. Families were compensated
for meal and travel expenses and given
coupons for local food stores. Written
informed parental consent was obtained for
all participants.
We used a mixed cross-sectional design,
with up to four visits over time allowed
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BACKGROUND: Soy formula containing estrogenic isoﬂavones is widely used in the United States.
Infants consuming soy formula exclusively have high isoflavone exposures. We wanted to study
whether soy formula prolonged the physiologic estrogenization of newborns, but available quanti-
tative descriptions of the natural history of breast and genital development are inadequate for
study design.
OBJECTIVE: We piloted techniques for assessing infants’ responses to the withdrawal from maternal
estrogen and gathered data on breast and genital development in infants at different ages. 
METHODS: We studied 37 boys and 35 girls, from term pregnancies with normal birth weights,
who were < 48 hr to 6 months of age, and residents of Philadelphia, Pennsylvania, during
2004–2005. One-third of the children of each sex and age interval were exclusively fed breast milk,
soy formula, or cow-milk formula. Our cross-sectional study measured breast adipose tissue, breast
buds, and testicular volume; observed breast and genital development; and collected vaginal wall
cells and information on vaginal discharge. We assessed reliability of the measures.
RESULTS: Breast tissue was maximal at birth and disappeared in older children, consistent with
waning maternal estrogen. Genital development did not change by age. Breast-milk secretion and
withdrawal bleeding were unusual. Vaginal wall cells showed maximal estrogen effect at birth and
then reverted; girls on soy appeared to show reestrogenization at 6 months. 
CONCLUSIONS: Examination of infants for plausible effects of estrogens is valid and repeatable.
Measurement of breast tissue and characterization of vaginal wall cells could be used to evaluate
exposures with estrogen-like effects.
KEY WORDS: breast bud, estrogen, human milk, infant formula, testis, vaginal maturation index.
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examinations: two boys and two girls in each
of seven age intervals and three feeding regi-
mens (Table 1). A group of infants unselected
on feeding regimen would consist mostly of
those fed cow milk–based formula, especially
as they got older. We thus chose to recruit
children who had been fed reasonably homo-
geneous regimens of breast milk, cow
milk–based formula, or soy formula, to guard
against unexpected variation in our end points
related to feeding method and to ensure that
our results would apply more broadly.We
allowed feeding variations immediately after
birth and in older children (Table 1). We
deemed nonsoy feeding immediately after
birth insigniﬁcant. We allowed some ﬂexibil-
ity for older children fed solids. Examiners
were not blinded to feeding regimen. We
assumed that parental report of feeding his-
tory was sufﬁciently accurate, because the pri-
mary purpose of the study was to develop and
test methods, not to test hypotheses about
feeding group differences. 
Physical examination. Our physical exam-
ination is adapted from the New Ballard score
(Ballard et al. 1979, 1991). The Ballard score
measures, among other things, the progres-
sively greater effect of the mother’s circulating
estrogen on the fetus. Ballard scores are com-
monly used in hospital nurseries in the United
States to estimate gestational age in the new-
born. We used it to measure the involution of
the estrogenized term infant’s organs over the
ﬁrst 6 months, assuming that regression would
look like progression in reverse. We examined
breasts and genitalia, we noted the presence of
milk at the nipple and blood in vaginal dis-
charge, and we collected vaginal wall cells.
One author (J.L.B.) conducted a 1-day onsite
workshop to train staff before the study began.
The examiners were two experienced pediatric
nurses. Each examiner performed approxi-
mately half of the examinations.
The palpability of adipose tissue in the
breast was recorded (yes, no). We observed
the infants for breast secretions. We assessed
the diameter of breast buds, if present, using a
custom set of beads. These disc-shaped beads,
in 2-mm increments from 4 mm to 22 mm,
were strung in an ordered set. The examiner
pinched the breast bud between finger and
thumb and simultaneously found the closest
bead from the string held in the other hand.
Each subject’s measurement was the average
of triplicate measurements from each breast. 
We used a mockup to train examiners and
to assess validity of breast bud measurements.
Examiners practiced estimating breast bud
size using a padded board with various sized
beads placed beneath its chamois cover. The
examiner palpated it and estimated the size of
the hidden bead using a second exposed set.
For validation, the two examiners were tested
using a random sequence of hidden beads.
Validation was conducted in two sessions
about 2 months apart; the ﬁrst used 20 hid-
den beads and the second used 15. The ﬁrst
session took place before any study exams; the
second came after experience with subjects.
Female external genitalia were assigned
one of four categories (enlarged minora,
majora and minora equally prominent, majora
large and minora small, majora cover clitoris
and minora). Appearance of the prepuce was
classified as prominent or not. Vaginal dis-
charge was characterized by presence or
absence and bloody or not. We collected
vaginal wall cells with infant recumbent,
opening the infant’s legs and using a cotton-
tipped swab to rub the introitus for 10 sec.
The swab was placed in a vial of Cyto-Rich
preservative and sent to CHOP’s contract lab-
oratory to be processed as a Papanicolaou
smear. Slides were read by standard methods
and a vaginal maturation index calculated as
the percent superficial cells plus half of the
percent intermediate cells. 
Appearance of the testis (retractile,
descending, down, pendulous) and the scrotal
rugae (rare, few, good, deep) were recorded.
We located and noted the position of testes
not in the scrotum. We found that commer-
cial Prader (orchidometer) beads (Prader
1966) were too large and insufﬁciently gradu-
ated for newborns; therefore, we commis-
sioned smaller beads in smaller increments
(sizes 0.5–3.0 mL in 0.5-mL increments). We
measured each testis once and used the aver-
age of the two as each subject’s measurement.
Prader beads are accepted as valid (Karaman
et al. 2005) for peripubertal boys; in infants,
Cassorla et al. (1981) reported using beads of
the same sizes we used.
Statistical analyses. Data analysis consisted
of descriptive statistics and tests for age trends.
We tested trend using the Cochran–Armitage
test (Agresti 1990) for binary outcomes, and
the Jonckheere–Terpstra test (Hollander and
Wolfe 1973) for polytomous outcomes. We
used paired t-tests to examine left–right differ-
ences in paired organs. We examined the tra-
jectory of maturation index as a function of
age and the square root of age using cubic-
spline regression techniques that accounted for
between-subject and within-subject sources of
variation. Statistical analysis employed SAS
software (SAS Institute Inc., Cary, NC, USA)
or StatXact software (Cytel Software
Corporation, Cambridge, MA, USA).
Results
We have data from 88 physical examinations
from 72 children, due to minor overrecruit-
ment. Children were allowed up to four
examinations over time. One girl had three
examinations, seven girls had two examina-
tions each, and 27 girls had a single examina-
tion each, for a total of 44 examinations of 35
girls. One boy had four examinations, four
boys had two examinations each, and 32 boys
had a single examination each, for a total of
44 examinations of 37 boys. Some analyses
have smaller sample sizes because some
responses were missing. Race/ethnicity of
children was reported by the parent; of the 72
children, 4% were Asian or Pacific Islander,
70% were black not of Hispanic origin, 26%
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Table 1. Nominal age, allowable age ranges, and feeding regimens determining eligibility, 2004–2005.
Feeding regimens
Nominal age Allowable age ranges (days) Breast milka Cow milk formulaa Soy formula
< 48 hr  age < 2 Breast milk exclusively Cow milk formula exclusively Soy formula exclusively
1 week  2 < age ≤ 10 Breast milk exclusively Cow milk formula exclusively Soy formula exclusively
2 weeks  10 ≤ age ≤ 17 Breast milk exclusively Cow milk formula exclusively Soy formula exclusively
3 weeks  17 ≤ age ≤ 24 Breast milk exclusively Cow milk formula exclusively Soy formula exclusively
(hospital nursery exception)b (hospital nursery exception)b
1 month 24 ≤ age ≤ 42 Breast milk exclusively Cow milk formula exclusively Soy formula exclusively
(hospital nursery exception)b (hospital nursery exception)b
3 months 70 ≤ age ≤ 98 Breast milk exclusively or  Cow milk formula exclusively Soy formulac
with cow-milk supplementation (hospital nursery exception)b (hospital nursery exception)b
6 months 154 < age ≤ 182  Breast milk exclusively or  Cow milk formula exclusively Soy formulac
with cow-milk supplementation (hospital nursery exception)b (hospital nursery exception)b
aRestriction: Breast milk and cow milk regimens prohibit any soy foods in baby’s lifetime. bHospital nursery exception: Cow milk regimen allowed breast milk, and soy formula regimen
allowed breast milk or cow milk while baby was in the hospital nursery immediately after birth. Exclusive feeding of ultimate regimen was required for at least 2 weeks before study
examination. cSoy formula exception: For older children, soy formula regimen must have been fed exclusively and continuously for at least two-thirds of the child’s lifetime, including the
2 weeks before study examination.were white not of Hispanic origin, and none
were of Hispanic origin.
Children were recruited equally among
the three feeding regimens and seven age
groups (Table 1). Children recruited into the
breast-feeding category at older ages (3–6
months) were allowed supplementation with
cow’s milk formula; however data on the pro-
portion of children who were “pure” breast-
fed versus those who received supplements of
cow’s milk were not collected. 
Assessment of breast bud diameter using
beads appeared valid and repeatable. For the
validity of breast bud assessment, one exam-
iner estimated the diameter of the hidden bead
correctly in 40 of 45 trials (89%) and was off
by at most one bead (2 mm); the other esti-
mated correctly in 35 of 45 trials (78%) and
was also off by at most one bead. Accuracy
increased with experience; the rates of correct
estimation in the second session were 93%
and 87%, respectively. We also assessed
repeatability through triplicate measurements
of each breast. Although necessarily contem-
poraneous, the triplicate measurements on a
single breast never varied (75 breasts with
buds present).
Average breast bud diameter did not differ
between left and right breasts. Maximum dif-
ference in an individual was 4 mm in girls
and 15 mm in boys. All 12 subjects < 2 days
old had palpable buds in both breasts. Breast
bud diameter was also maximal within 1 week
after birth and was smaller in older children
(Figure 1); boys and girls had the same aver-
age diameter (Table 2). The proportion of
children with palpable buds was smaller in
older children (trend p < 0.0001 and 0.0003
for boys and girls, respectively); at 1 month or
after, only 5 of 20 girls (25%) and 1 of 20
boys (5%) had a palpable breast bud. 
Adipose tissue was palpable on at least one
breast of every child in every age interval. The
proportion palpable on both breasts was
smaller in older children, however (trend
p < 0.0001 and 0.0005 in boys and girls,
respectively). Few children had detectable
milk secretion at the nipple: 9 of 44 boys
(20%) and 5 of 44 girls (11%). All children
with detectable breast secretion were older
than 2 days but younger than 42 days.
Female genitalia evidenced some change
in appearance across age intervals but showed
no evidence of postpartum regression. The
proportion of girls with detectible vaginal dis-
charge was constant across age intervals; 38 of
44 girls (86%) exhibited vaginal discharge
overall, but no blood was observed in any
vaginal discharge. 
We collected evaluable vaginal wall cell
samples from all 44 visits. The maturation
index of vaginal wall cells was maximal in
newborns, lowest in the 1-month olds, and
somewhat higher in the older girls (Figure 2).
The curvature was statistically significant
(p < 0.0001). In addition, feeding regimen
appeared to inﬂuence the trajectory of matu-
ration index (p = 0.07). Differences among
feeding regimens appeared minimal among
girls younger than about 30 days; among girls
older than that, however, girls fed soy formula
tended to have higher maturation index.
We saw no consistent differences in scro-
tal or testicular anatomy at different ages. In
every age interval, most of the boys exhibited
“good rugae”; overall, only 1 of 44 examina-
tions showed “deep” rugae, 38 showed
“good” rugae, whereas the remaining 5 had
“few” or “rare” rugae. Most boys (half or
more of the boys in every age interval) had
both testes “down,” for a total of 31 of 44
boys (70%). Four boys (9%) had both testes
retractile; five boys (11%) had both testes
pendulous. The remaining examinations were
of boys whose testes were in mixed positions:
one “descending and down,” and three “down
and pendulous.” Mean testis size was constant
across age intervals with an upswing in the
oldest age interval (6 months) (Table 3). We
saw no difference in mean testis volume
between left and right sides (p = 0.53) with
a maximum absolute difference for any
individual boy of 0.5 mL. 
Discussion
The techniques of the Ballard scale for physi-
cal examination of estrogen responsive tissues
in infants are readily taught, and breast bud
diameter is validly assessed. Vaginal cytology
specimens are easy and atraumatic to collect.
All examinations appear precise enough for
research protocols. 
Not all tissues that show developmental
response to estrogen reverted when maternal
estrogen was withdrawn at birth. Although
breast tissue was maximal in newborns and
Bernbaum et al.
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Table 2. Mean and median breast bud diameter (mm) by sex and nominal age.
Girls Boys
Nominal age No. Mean Median No. Mean Median
< 48 hr 6 9.8 10.3 6 8.0 8.0
1 week 6 9.6 8.5 6 10.2 9.3
2 weeks 6 0.0 0.0 6 7.5 8.0
3 weeks 6 3.8 0.0 6 4.2 2.5
1 month 7 5.1 0.0 7 1.3 0.0
3 months 7 2.0 0.0 6 0.0 0.0
6 months 6 2.3 0.0 7 0.0 0.0
Table 3. Mean, minimum, and maximum testis
volume (mL) by nominal age.
Nominal age No. Mean Range
< 48 hr 6 0.67 0.5–1.0
1 week 6 0.63 0.5–1.0
2 weeks 6 0.75 0.5–1.0
3 weeks 6 0.71 0.5–1.0
1 month 7 0.75 0.5–1.5
3 months 6 0.67 0.5–1.0
6 months 7 1.04 0.5–1.5
Figure 1. Breast bud diameter (mm) versus age (days) for girls (A) and boys (B). Line segments connect
observations from multiple visits by the same child at different ages.
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Figure 2. Maturation Index (%) of vaginal wall cells
versus age (days). Line segments connect obser-
vations from multiple visits by the same child at
different ages.
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Soysmaller in older children, external genitalia
showed few differences by age. Vaginal bleed-
ing, from withdrawal of maternal estrogen’s
trophic effect on the infant’s endometrium,
was not observed. Infants synthesize some
estrogen, and it may mitigate the effects of
withdrawal of maternal estrogen. Vaginal wall
cells are responsive to maternal estrogen,
appear to lose that effect by 1 month, and
then may respond both to estrogen synthe-
sized by the girl and to soy formula. We
looked for milk secretion in infants because
we thought exogenous estrogen might inhibit
prolactin’s promotion of milk synthesis
(Guyda and Friesen 1973), but milk secretion
was rare. We propose that a longitudinal set
of physical examinations of girls aimed at
detecting the effects of exogenous estrogen
should be performed weekly to fortnightly for
the ﬁrst 1–2 months. Vaginal cytology speci-
mens need to be collected for > 6 months.
Milk secretion or vaginal bleeding should be
asked about because they have a plausible
endocrine basis, but will be infrequent.
Our physical ﬁndings, like those of others
(Alexander et al. 1992; Donovan et al. 2007),
show more variability than Ballard reported
(Ballard et al. 1979, 1991) in term infants.
Ballard reports labia majora cover the clitoris
and minora at term, which we saw in all girls
older than 17 days but only in half of the
younger girls. Ballard saw deep scrotal rugae
at term, but most of our boys had “good”
rugae, only one had “deep” rugae. 
We measured testicular volume in infants
48 hr to 6 months of age using orchidometer
beads that were smaller and in smaller incre-
ments (0.5 mL) than the norm. Mean testicu-
lar volume (0.7 mL) in our younger age
intervals was less than others report, but was
similar by 6 months of age (1.04 mL).
Average testicular volume from tissue
sections in 1-year-olds was 1.1 mL (range
0.3–1.9 mL) in autopsy material from
36 Danish children who died accidentally
(Müller and Skakkebæk 1983). Orchido-
metric assessment in Taiwanese newborns
showed mean volume of 1.3 ± 0.3 mL (Chin
et al. 1998). Chemes (2001) and Sak et al.
(1993) reported infant testicular volumes of
approximately 1 mL. In a small but longitu-
dinal study, Cassorla et al. (1981) measured
testicular volumes with orchidometer beads
of the same sizes as ours monthly in 10 U.S.
boys from birth to 6 months of age. Volume
increased from birth (1.1 mL) to 2–3 months
(2.0 mL), and then declined (1.5 mL at 6
months) (Cassorla et al. 1981). The increase
is plausibly related to the reported peak in
testosterone at 2 months (Grumbach 2005).
Assuming the peak occurs regularly, detect-
ing it may require the smaller variability in
longitudinal data, and will require monthly,
or more frequent, exams. 
Ballard reported that term infants of both
sexes had breast buds of 5–10 mm diameter
and palpable adipose breast tissue (Ballard
et al. 1979, 1991). Among 21 term infants
followed by McKiernan and Hull (1981),
mean breast bud diameter was 9 mm at birth,
13 mm at 2 weeks, and receded to 10 mm at
1 month, with breast buds in girls larger than
in boys. We did not observe an increase in
breast bud size postnatally nor a sex differen-
tial, and can offer no explanation for these
differences. Among 1,126 Danish infants
with median age of 3 months, 79% had
breast buds, girls more often than boys; buds
were larger in girls (5.7 vs. 4.9 mm) and asso-
ciated with endogenous estradiol levels
(Schmidt et al. 2002). McKiernan and Hull
(1981) observed that most infants still had
palpable adipose breast tissue at 6 months, as
did ours, and that most 1-week-old term
infants had some milk secretion, but ours
did not. 
We know of no other studies that report
vaginal maturation index from vaginal wall
cells in infants, although it can be used both
in the diagnosis and the evaluation of treat-
ment for precocious puberty in girls (Comite
et al. 1981), and should have a shorter
response time than, say, breast size. The com-
ponents of vaginal maturation index are usu-
ally used as a measure of estrogen effects in
adult women (Hammond 1977; van der Laak
et al. 1999). In a “normal child,” one would
expect almost 100% parabasal cells, few inter-
mediate, and 0% superﬁcial cells, for a vaginal
maturation index of nearly 0%, whereas a
peripubertal girl may have a virtually no
parabasal, 90% intermediate, and about 10%
superficial for a vaginal maturation index of
about 55%. Infant girls’ cells responded as
expected to their in utero exposure to mater-
nal estrogen (Farage and Maibach 2006); at
1 month, this effect was not apparent. Older
girls had higher vaginal maturation index val-
ues, which may represent the effect of their
own synthesis of estrogen. Older soy-fed girls
had somewhat higher vaginal maturation
index values than girls of the same age on
other diets. This observation, though perhaps
a chance occurrence, is plausible and deserv-
ing of follow-up. We recommend use of vagi-
nal maturation index in infant girls. A
possible parallel measure in boys, called the
urocytogram (Preeyasomba and Kenny
1966), exploits the hormonal responsiveness
of urethral cells from spun urine. We did not
evaluate this end point but now would con-
sider using it. 
Our study, although small and primarily
cross sectional, suggests choices among
responses for further studies. For example,
our data suggest that genitalia do not vary
much by age and thus will not respond to
exogenous estrogen with delayed regression.
Breast tissue did appear responsive, as did
vaginal wall cells. Withdrawal vaginal bleed-
ing and breast milk are worth noting but are
infrequent. This study was a pilot and too
small for reliable inference about feeding regi-
mens. Our results indicate that these methods
can be used validly and repeatably in infants;
they may allow more direct, interpretable
investigations of the infant’s response to
estrogen-like compounds.
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